Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

Completed · Phase 1

Conditions studied: Keloid, Scar, Incision, Excision Margin

In brief

To evaluate the saftye and effectiveness of AIV001 treatment on scar formation and/or keloid scar recurrence following keloidectomy.

Key facts

Study ID
NCT04827875
Run by
AiViva BioPharma, Inc.
People needed
25
Starts
2021-06-23
Expected to finish
2022-12-15
Last updated by the study team
2024-12-27

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.